{"id":303021,"date":"2020-09-23T16:40:24","date_gmt":"2020-09-23T14:40:24","guid":{"rendered":"https:\/\/www.pcnen.com\/portal\/?p=303021"},"modified":"2020-09-23T16:40:24","modified_gmt":"2020-09-23T14:40:24","slug":"ruski-lijek-areplivir-obnavlja-pluca-posle-covida-19","status":"publish","type":"post","link":"https:\/\/www.pcnen.com\/portal\/2020\/09\/23\/ruski-lijek-areplivir-obnavlja-pluca-posle-covida-19\/","title":{"rendered":"Ruski lijek &#8216;Areplivir&#8217; obnavlja pluc\u0301a posle covida 19"},"content":{"rendered":"<p>Ovo je saop\u0161tila na dana\u0161njoj konferenciji &#8220;Rezultati klini\u010dkih ispitivanja leka \u2018Areprivil\u2019 kod pacijenata oboljelih od virusa korona\u201c, direktorka Medicinskog instituta Nacionalnog istra\u017eiva\u010dkog Mordovskog univerziteta, Larisa Balikova.<\/p>\n<p>Pojava ne\u017eeljenih efekata kod pacijenata koji se lije\u010de od kovida 19 bila je \u010desta kao kod pacijenata koji su primali standardnu terapiju. Lijek se izdaje na recept i prepisuje ga ljekar, prenosi Sputnjik.<\/p>\n<p>Areplivir je napravljen u farmaceutskoj kompaniji Promomeda na bazi lijeka iz saranske farmaceutske kompanije Biohimika, koji je zvani\u010dno odobren u Rusiji u junu.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Terapija Areprivilom pru\u017ea nevjerovatno pobolj\u0161anje stanja pluc\u0301a, skoro do potpune normalizacije kod vec\u0301ine pacijenata,<\/p>\n","protected":false},"author":1,"featured_media":303022,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[14],"tags":[],"class_list":["post-303021","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vijesti"],"_links":{"self":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/303021","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/comments?post=303021"}],"version-history":[{"count":1,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/303021\/revisions"}],"predecessor-version":[{"id":303023,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/303021\/revisions\/303023"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/media\/303022"}],"wp:attachment":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/media?parent=303021"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/categories?post=303021"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/tags?post=303021"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}